NCT05829603View on ClinicalTrials.gov

Dose-finding Study for the Combination of DMT and Harmine in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 5, 2023

Primary Completion Date

September 17, 2023

Study Completion Date

October 17, 2023

Conditions
Healthy
Interventions
DRUG

Dimethyltryptamin (DMT) & Harmine

Six varying doses of a fixed-combination formulation of Dimethyltryptamin (DMT) and harmine

Trial Locations (1)

8032

University Hospital of Psychiatry Zurich, Zurich

All Listed Sponsors
lead

Reconnect Labs

INDUSTRY

NCT05829603 - Dose-finding Study for the Combination of DMT and Harmine in Healthy Subjects | Biotech Hunter | Biotech Hunter